StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cancer cure - President Biden to sign order boosting biotech

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Sep 12, 2022 10:58am

76 Views

Post# 34956562

RE:Cancer cure - President Biden to sign order boosting biotech

Ya it definitely looks promising

NewToInvesting7 wrote: Any thoughts on how the executive order Presiden Biden is signing today will impact StageZero, if at all?

Supposedly, biotechnologies will be part of he effort, and he will make note of the National Cancer Institute study aimed at identifying blood tests that can detect one or more cancers with the goal of early detection in cancer patients.

Would have been great to see StageZero on top of this, but maybe they will mention it on the next call or release a tweet?

Cheers!